EAACI focuses on planetary health as a key feature of the research agenda
VALENCIA, Spain, June 04, 2024 (GLOBE NEWSWIRE) -- The Closing Ceremony of the EAACI Congress 2024, a meeting forum for experts in Allergy and Immunology from countries all over the world, has taken place. At the closing of the Congress, Dr. María José Torres, Professor of Medicine and Head of the Allergology Service of the Regional University Hospital of Malaga, takes the lead as the new President of EAACI; she is the first Spanish professional to hold this position.
In her speech at today's plenary session entitled “Drug allergy: today and tomorrow,” Dr. Torres stressed that “drug allergy is a huge burden on healthcare systems and represents, in some cases, a threat to the patient's life.”
In recent years, there has been a significant increase in interest in the design of predictive models to stratify patients' risk of being allergic. “It is essential to continue researching and working towards the goal of efficient precision medicine,” says Dr. Torres.
Dr. Ioana Agache, who chairs EAACI's Research and Outreach Committee (ROC), details that “with allergic diseases and asthma as prototypical environmentally driven diseases, Planetary Health is another key feature of EAACI's research agenda.”
The ROC's key objectives include being “the exchange platform for scientists across the EAACI Research Network, a space where to formulate recommendations and quality criteria, forge varied educational programs and ensure professional development opportunities through its collaboration with EAACI junior members and all other stakeholders,” she notes.
The ERN (EAACI Research Network) seeks to identify and coordinate allergy and asthma research in Europe. “It currently includes almost 100 institutions from Europe and around the world. It should guide the future of allergy and asthma research in Europe and foster synergies and cooperation, reduce duplication of efforts and identify gaps and priorities that need the attention of funding organizations,” concludes Ioana Agache.
Press Contact EAACI
+41 44 205 55 33
communications@eaaci.org
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/76440242-ab97-4b62-b880-c1b91b09ceb3
-
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cVANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a di2024-06-17
-
Indonesia Stock Exchange Partners with Nasdaq to Upgrade Market InfrastructureTechnology partnership will further enhance overall resilience and integrity of the exchange, while supporting the rapid deployment of new products2024-06-17
-
Adalvo 的 Liraglutide 預充式注射筆成為歐盟首款獲得批准的仿製藥馬爾他聖瓜安, June 17, 2024 (GLOBE NEWSWIRE) -- Adalvo 宣布 Liraglutide 預充式注射筆成功取得 DCP 批准,成為歐盟首款獲得批准的仿製藥。 根據 IQVIA 的報2024-06-17
-
促进生育,助力三胎——“三胎免费生”联合公益行动正式启动为积极响应国家号召实施三胎生育政策,扩大妇幼服务健康供给,在云南省优生优育妇幼保健协会指导下,昆明广播电视台联合昆明安琪儿妇产医院,于6月13日在昆明广播2024-06-17
-
学党史传承红色精神 守党纪筑牢自律防线——平安养老险湖南分公司党支部开展主题党日活动七一前夕,平安养老险湖南分公司党支部全体成员走进“千年学府、百年师范”——湖南第一师范,开展了一次学史明理、学史增信、学史崇德、学史力行的主题党日活动。重2024-06-17